肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2017 EANM/SNMMI指南：前列腺癌68Ga-PSMA PET/CT检查

2017-03-10 欧洲核医学协会 Eur J Nucl Med Mol Imaging. 2017 Mar 10.

前列腺癌PET/CT

2017年3月，欧洲核医学协会(EANM)联合核医学和分子影像学学会(SNMMI)共同发布了前列腺癌68Ga-PSMA PET/CT检查指南，目的是为前列腺癌68Ga-PSMA PET/CT 检查提出相关建议。

中文标题：

2017 EANM/SNMMI指南：前列腺癌68Ga-PSMA PET/CT检查

英文标题：

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

发布机构：

欧洲核医学协会

发布日期：

2017-03-10

简要介绍：

2017年3月，欧洲核医学协会(EANM)联合核医学和分子影像学学会(SNMMI)共同发布了前列腺癌68Ga-PSMA PET/CT检查指南，目的是为前列腺癌68Ga-PSMA PET/CT 检查提出相关建议。


拓展指南：与前列腺癌相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 EANM/SNMMI指南：前列腺癌68Ga-PSMA PET/CT检查)] GetToolGuiderByIdResponse(projectId=1, id=38a181c001396272, title=2017 EANM/SNMMI指南：前列腺癌68Ga-PSMA PET/CT检查, enTitle=68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0, guiderFrom=Eur J Nucl Med Mol Imaging. 2017 Mar 10., authorId=null, author=, summary=2017年3月，欧洲核医学协会(EANM)联合核医学和分子影像学学会(SNMMI)共同发布了前列腺癌68Ga-PSMA PET/CT检查指南，目的是为前列腺癌68Ga-PSMA PET/CT 检查提出相关建议。, cover=, journalId=null, articlesId=null, associationId=401, associationName=欧洲核医学协会, associationIntro=欧洲核医学协会成立于1985年9月6日，是一个非营利性的专业医疗协会，已经拥有超过3000名会员涉及临床医生、科学家以及专业领域的相关工作人员。协会主要致力于促进整个欧洲及欧洲以外核医学的发展。, copyright=0, guiderPublishedTime=Fri Mar 10 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=2017年3月，欧洲核医学协会(EANM)联合核医学和分子影像学学会(SNMMI)共同发布了前列腺癌68Ga-PSMA PET/CT检查指南，目的是为前列腺癌68Ga-PSMA PET/CT 检查提出相关建议。 <div><br> </div> 拓展指南：<strong>与<font color="red">前列腺癌</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=ace391c0013ea980" title="NCCN临床实践指南：前列腺癌（2017.V2）" target="_blank" style="font-size: 9pt;">NCCN临床实践指南：前列腺癌（2017.V2）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=88b3f1c0013651b7" title="前列腺癌的骨健康和骨靶向治疗：基于循证医学项目 - 癌症治疗安大略省临床实践指南2017（重复）" target="_blank">前列腺癌的骨健康和骨靶向治疗：基于循证医学项目 - 癌症治疗安大略省临床实践指南2017（重复）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a72131c00136352c" title="2017 ACR/ABS实践参数：前列腺癌经会阴永久性近距离放射治疗" target="_blank">2017 ACR/ABS实践参数：前列腺癌经会阴永久性近距离放射治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5cc1e1c001358a79" title="2017 CCO临床实践指南：前列腺癌骨健康和骨靶向治疗" target="_blank">2017 CCO临床实践指南：前列腺癌骨健康和骨靶向治疗</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C" target="_blank">有关前列腺癌更多指南</a></ul>, tagList=[TagDto(tagId=942, tagName=前列腺), TagDto(tagId=4024, tagName=癌), TagDto(tagId=690, tagName=PET/CT)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12534, appHits=150, showAppHits=0, pcHits=9542, showPcHits=4380, likes=116, shares=4, comments=6, approvalStatus=1, publishedTime=Mon Mar 20 09:36:20 CST 2017, publishedTimeString=2017-03-10, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Mon Mar 20 09:36:20 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:42:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 EANM/SNMMI指南：前列腺癌68Ga-PSMA PET/CT检查)])
2017 EANM/SNMMI指南：前列腺癌68Ga-PSMA PET/CT检查
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1178927, encodeId=d39511e892754, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=deea6441432, createdName=ms5000001969223926, createdTime=Thu Dec 30 17:46:40 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972579, encodeId=791b9e257923, content=不错不错啊<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdc43108304, createdName=haoranliu666, createdTime=Thu Jun 10 15:50:16 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251380, encodeId=a97f25138038, content=不错，正好需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sun Oct 08 19:01:05 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181365, encodeId=fe32181365e3, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 20 09:56:50 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
    2021-12-30 ms5000001969223926

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1178927, encodeId=d39511e892754, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=deea6441432, createdName=ms5000001969223926, createdTime=Thu Dec 30 17:46:40 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972579, encodeId=791b9e257923, content=不错不错啊<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdc43108304, createdName=haoranliu666, createdTime=Thu Jun 10 15:50:16 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251380, encodeId=a97f25138038, content=不错，正好需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sun Oct 08 19:01:05 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181365, encodeId=fe32181365e3, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 20 09:56:50 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
    2021-06-10 haoranliu666

    不错不错啊#肿瘤#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1178927, encodeId=d39511e892754, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=deea6441432, createdName=ms5000001969223926, createdTime=Thu Dec 30 17:46:40 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972579, encodeId=791b9e257923, content=不错不错啊<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdc43108304, createdName=haoranliu666, createdTime=Thu Jun 10 15:50:16 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251380, encodeId=a97f25138038, content=不错，正好需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sun Oct 08 19:01:05 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181365, encodeId=fe32181365e3, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 20 09:56:50 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
    2017-10-08 lxhxixi

    不错，正好需要

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1178927, encodeId=d39511e892754, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=deea6441432, createdName=ms5000001969223926, createdTime=Thu Dec 30 17:46:40 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972579, encodeId=791b9e257923, content=不错不错啊<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdc43108304, createdName=haoranliu666, createdTime=Thu Jun 10 15:50:16 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251380, encodeId=a97f25138038, content=不错，正好需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sun Oct 08 19:01:05 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181365, encodeId=fe32181365e3, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 20 09:56:50 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
    2017-03-20 Chongyang Zhang

    签到学习了很多。

    0

相关指南

2016 AUA/SAR共识声明：先前活检阴性患者前列腺MRI检查和MRI定向活检  

美国泌尿外科学会(AUA,American Urological Association) · 2016-06-16

2014 EAU 非神经源性男性下尿路症状（LUTS）包括良性前列腺梗阻（BPO）管理指南

欧洲泌尿外科学会(EAU,European Association of Urology) · 2014-04-01